| Literature DB >> 25386679 |
Peter Glen1, Michaël Chassé2, Mary-Anne Doyle3, Ahmed Nasr4, Dean A Fergusson2.
Abstract
BACKGROUND: There is no consensus as to what extent of "wrap" is required in a fundoplication for correction of gastroesophageal reflux disease (GERD).Entities:
Mesh:
Year: 2014 PMID: 25386679 PMCID: PMC4227692 DOI: 10.1371/journal.pone.0112417
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow chart of study selection process identifying studies comparing partial and complete fundoplication.
Study and patient characteristics for studies comparing partial and complete fundoplication.
| Study (Year) | Study Design | Indication for Surgery | Partial Wrap Technique (n) | Complete Wrap Technique (n) | Co-Intervention | Length of Follow Up (Months) | Definition of Failed Reflux Surgery | NI patients Included in study | Median Age Age Range (years) |
|
| RC | Refractory GERD +/− UGIS +/−24 pH | Toupet (56) | Nissen (13) Nissen-Rosetti (70) | +/− Gastrostomy | 10 | GERD Symptoms + UGIS or pH | Y | NR 0.25–18 |
|
| RC | Refractory GERD + UGIS or EGD +/− pH | Thal (20) | Nissen (27) | +/− Gastrostomy +/− Pyloroplasty | 12–108 | GERD Symptoms | Y (all) | 5.3 0.5–20 |
|
| RC | Refractory GERD + UGIS +/− pH or EGD | Boix-Ochoa (27) | Nissen (32) | +/− Gastrostomy | 6–216 | GERD Symptoms | Y | NR 0.05–9 |
|
| RCT | Encephalopathy Refractory GERD + pH study | Vertical Gastric Plication (7) | Nissen (7) | +/− Gastrostomy | 6 | GERD Symptoms, Clinical Score (not described) | Y (all) | NR 0.3–12.3 |
|
| RC | Refractory GERD or severe pulmonary symptoms | Toupet (201) | Nissen (175) | +/− Gastrostomy | NR | GERD symptoms requiring surgical revision or medical therapy | NR | NR NR |
|
| RC | Refractory GERD +/− pH or EGD Manometry or UGIS | Thal (24) Toupet (4) | Nissen (13) | +/− Gastrostomy +/− Pyloroplasty | 6–47 | GERD Symptoms requiring surgical revision or medical therapy | Y (all) | 9.6 0.1–19 |
|
| RC | Clinical GERD +/− pH or EGD Manometry or UGIS | Thal (33) | Nissen (126) | NR | 1–186 | GERD Symptoms requiring surgical revision | Y | NR NR − 2 |
|
| RCT | Refractory GERD + pH or EGD or UGIS | Thal (86) | Nissen (89) | +/− Gastrostomy | 1–109 | GERD Symptoms requiring surgical revision or medical therapy | Y | 3.1 0.1–21 |
|
| RC | Prior EA repair and presence of GERD symptoms | Toupet (18) Thal (5) Other (8) | Nissen (16) | +/− Gastrostomy +/− Hiatal Repair | 12–213 | GERD Symptoms recorded following EA repair | N | NR NR |
|
| RC | pH study | Thal (195) | Nissen (135) | +/− Pyloroplasty | 3 | Persistent abnormal pH study | Y | 0.25 0.02–15 |
|
| RC | GERD Symptoms UGIS +/− EGD +/− pH Study | Boix-Ochoa (53) | Nissen (56) | +/− Gastrostomy | 19–76 | GERD Symptoms requiring surgical revision or medical therapy | Y | NR 1.5–11 |
|
| RC | Refractory GERD + UGIS, pH, EGD | Thal (21) | Nissen (23) | +/− Gastrostomy | 6–108 | Persistent Esophagitis | Y | NR 0.2–15.6 |
|
| RC | Refractory GERD +/− EGD or pH or UGIS | Watson (55) | Nissen (76) | +/− Gastrostomy | 0–90 | Poor or Bad outcome, determined by surgeon | Y | 2.6 0.05–16.9 |
|
| RC | Refractory GERD +/− UGIS or EGD or pH | Toupet (154) | Nissen (102) | NR | 12–96 | Symptoms confirmed by UGIS +/− EGD or pH | N | NR 0.25–16 |
RC Retrospective Cohort; RCT Randomized Control Trial; GERD Gastroesophageal Reflux Disease; UGIS Upper Gastrointestinal Series; pH Twenty-Four Hour pH study; EGD Esophagoscopy; EA Esophageal Atresia; NI Neurologically Impaired; Y Yes; N No; NR Not Recorded.
Figure 2Recurrence of reflux symptoms following partial versus complete fundoplication (RCT).
Figure 3Recurrence of GERD following partial versus complete fundoplication (observational studies).
Figure 4Recurrence of GERD following partial versus complete fundoplication in neurologically impaired patient subgroup (RCT).
Reported complications, and number of patients affected for each fundoplication technique.
| Complication | Kazerooni | Van der Zee | Ceriati | Georgeson | Strecker | Cohen | Weber | Subramamiam | Allal | Durante | Goessler | Wagener | Kubiak | Levin |
| Death | 24 RNL | C: 1 P: 2 | C: 1 P: 0 | 2 RNL | C: 1 P: 5 | 6 RNL | 1 RNL | C: 1 P: 1 | 1 RNL | C:12 P: 5 | C:21 P:10 | |||
| Dysphagia | C: 2 P: 5 | 2 RNL | C:20 P: 7 | C: 3 P: 0 | C: 7 P: 4 | C: 6 P: 1 | C:20 P:18 | C: 6 P:14 | ||||||
| Gas-Bloat Syndrome | C: 8 P: 2 | C: 1 P: 0 | 3 RNL | C: 5 P: 0 | RNL | 2 RNL | C: 3 P: 0 | |||||||
| Paraesophageal Hernia | C:12 P: 0 | C: 2 P: 0 | C: 1 P: 0 | C: 0 P: 1 | 6 RNL | C: 2 P: 5 | C: 5 P: 4 | |||||||
| Wrap Disruption | 6 RNL | C: 3 P: 0 | C: 2 P: 5 | 2 RNL | 1 RNL | C: 1 P: 1 | C: 2 P: 6 | |||||||
| Wrap Migration | 2 RNL | 1 RNL | C: 1 P: 0 | C: 0 P: 2 | 3 RNL | C: 1 P: 0 | ||||||||
| Small Bowel Obstruction | C: 1 P: 1 | C: 6 P: 0 | 2 RNL | 1 RNL | C: 1 P: 2 | |||||||||
| Pneumonia | C: 1 P: 0 | 1 RNL | C: 0 P: 2 | 6 RNL | C: 5 P: 1 | |||||||||
| Wrap Stricture | C: 3 P: 0 | 1 RNL | C: 3 P: 5 | |||||||||||
| Wound Dehiscence | C: 1 P: 0 | 1 RNL | 1 RNL | |||||||||||
| Infection | C: 1 P: 0 | C: 2 P: 1 | ||||||||||||
| Regurgitation | C: 1 P: 0 | C: 4 P: 6 | ||||||||||||
| Atelectasis | C: 1 P: 1 | 1 RNL | ||||||||||||
| Gastric Perforation | 1 RNL | C: 1 P: 0 | ||||||||||||
| Hematoma | 1 RNL | 1 RNL | ||||||||||||
| Peritonitis | 1 RNL | 1 RNL | ||||||||||||
| Pneumothorax | 1 RNL | C: 1 P: 0 | ||||||||||||
| Retching | C: 5 P: 1 | C: 4 P: 3 | ||||||||||||
| Bleeding | 2RNL | |||||||||||||
| Esophageal Perforation | 1 RNL | |||||||||||||
| Food Bolus | C: 1 P: 0 | |||||||||||||
| Gastric Torsion | 1 RNL | |||||||||||||
| Intussusception | C: 1 P: 0 | |||||||||||||
| Not Specified | C: 6 P: 4 | |||||||||||||
| Spleen Laceration | C: 1 P: 0 |
C: Complete Fundoplication; P: Partial Fundoplication; RNL: Reported, Not Listed by Fundoplication Type.
Figure 5Dysphagia following partial versus complete fundoplication.
Figure 6Modified Cochrane Risk of Bias evaluation of study quality.
Shaded: high risk of bias; checkered: unclear or indeterminate risk of bias; not shaded: low risk of bias.